Prospective Validation of Pooled Prognostic Factors in Women with Advanced Cervical Cancer Treated with Chemotherapy with/without Bevacizumab: NRG Oncology/GOG Study.
Clinical cancer research : an official journal of the American Association for Cancer Research.
Times cited: 5
Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240).
The Lancet. Oncology.
Times cited: 31
- Improved survival with bevacizumab in advanced cervical cancer. The New England journal of medicine. 2014 Academic Article GET IT
Molecular alterations in the pathogenesis of endometrial adenocarcinoma. Therapeutic implications.
Clinical and Translational Oncology.
Times cited: 15